Fennec Pharmaceuticals publishes corporate presentation highlighting PEDMARK expansion for cisplatin-induced hearing loss preventionPUBT·Aug 17 at 03:33 PMFENC-0.53%
FENC: Q2 revenue up 78% year-over-year, with record enrollments and strong growth momentumQuartr·Aug 11 at 09:44 AMFENC-0.53%
Biotech Stocks At 52-Week Highs - HALO +20% On Q2 Results, FENC, AVLN, AMLX, CHErttnews·Aug 10 at 04:53 AMFENC-0.53%HALO+1.93%
Fennec Pharmaceuticals former director Rosty Raykov disposes of 10,000 common shares worth $95,800PUBT·Aug 4 at 03:06 PMFENC-0.53%
Adherex Technologies (NASDAQ:FENC) Stock Price Up 0.2% - Here's WhyMarket Beat·Aug 3 at 11:20 PMFENC-0.53%
Adherex Technologies Inc. (NASDAQ:FENC) Receives Average Rating of "Moderate Buy" from AnalystsMarket Beat·Jul 10 at 03:29 AMFENC-0.53%
Fennec Pharma former director Rosty Raykov disposes of 9,599 common shares for $99,926.59PUBT·Jul 2 at 03:06 PMFENC-0.53%
